[Other] Incidence of safety events after immune checkpoint inhibitor initiation for advanced-stage non-small-cell lung cancer: a real-world study

LuisDT3010 Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-08-19 01:02
Reward20points

journalㄩFuture Oncology

AuthorsㄩDaniel C Beachler; Francois Xavier Lamy; Francesca Kolitsopoulos; Jade Dinh; Anahit Papazian; Aziza Jamal-Allial; Seyed Hamidreza Mahmoudpour; Elisabete Michelon; Patrice Verpillat

Published dateㄩ2022-8-

DOIㄩ10.2217/fon-2022-0308

PDF linkㄩhttps://www.tandfonline.com/doi/pdf/10.2217/fon-2022-0308

Article linkㄩhttps://doi.org/10.2217/fon-2022-0308

Article SourceㄩInforma UK Limited


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    150


Return to the list